IOSAT 130 mg Potassium Iodide Tablets, 5 Count
- 5 Packs of 14 tablets each equal to 70 tablets
- 130 mg Potassium Iodide per tablet
- One dose every 24 hours for no more than 10 days
- Reduces chance of thyroid damage in a radiation emergency
Meets all FDA requirements for potassium iodide as a radiation protective, and is labeled and packaged in accordance with US government guidelines. Has demonstrated all quality controls and passed all FDA requirements for purity, quality, safety, efficacy. Comes full strength (130 mg of potassium iodide per tablet) in accordance with FDA demands for complete thyroid blocking. Contains no potassium iodate or other adulterants. Contains only pure potassium iodide as the active ingredient. iOSAT [potassium iodide] is manufactured in the United States under strict FDA "GMP guidelines," and holds an approved "New Drug Application" (NDA). iOSAT [potassium iodide] was the first product of its kind (since 1982) and is the only product which can be purchased by local, state and federal governments. Is widely purchased by nuclear utilities. iOSAT [potassium iodide] offers unit dose packaging for maximum shelf-life and allows for individual tablet distribution without fear of loss of packaging integrity.
Informazio garrantzitsua
Osagaiak
Potassium Iodine
Lege oharra
FDAk ez ditu ebaluatu dieta-gehigarriei buruzko instrukzioak, eta ez dute diagnostikatu, tratatu, sendatu edo gaixotasun edo osasun-egoera saihesteko asmorik.
Produktuaren neurriak
8 x 6 x 2 inches; 2.47 ounces
Specifications
| Iraungitze-data | 2026ko abendua |
| Osagarri nagusia | S |
| Flavor | Desflavor |
| Elementuaren forma | Taula |
| Osagaiak | Potassium Iodine |
| Produktu mota | Mineral gehigarria |
| Unitate kopurua | 70. |
| Brand | Anbex |
| Tags | |
|---|---|
| Tags | |